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A B S T R A C T
ETS domain-containing protein-1 (ELK1) is a transcription factor important in regulating αvβ6 integrin ex-
pression. αvβ6 integrins activate the profibrotic cytokine Transforming Growth Factor β1 (TGFβ1) and are
increased in the alveolar epithelium in idiopathic pulmonary fibrosis (IPF). IPF is a disease associated with aging
and therefore we hypothesised that aged animals lacking Elk1 globally would develop spontaneous fibrosis in
organs where αvβ6 mediated TGFβ activation has been implicated. Here we identify that Elk1-knockout (Elk1−/
0) mice aged to one year developed spontaneous fibrosis in the absence of injury in both the lung and the liver
but not in the heart or kidneys. The lungs of Elk1−/0 aged mice demonstrated increased collagen deposition, in
particular collagen 3α1, located in small fibrotic foci and thickened alveolar walls. Despite the liver having
relatively low global levels of ELK1 expression, Elk1−/0 animals developed hepatosteatosis and fibrosis. The loss
of Elk1 also had differential effects on Itgb1, Itgb5 and Itgb6 expression in the four organs potentially explaining
the phenotypic differences in these organs. To understand the potential causes of reduced ELK1 in human disease
we exposed human lung epithelial cells and murine lung slices to cigarette smoke extract, which lead to reduced
ELK1 expression andmay explain the loss of ELK1 in human disease. These data support a fundamental role for
ELK1 in protecting against the development of progressive fibrosis via transcriptional regulation of beta integrin
subunit genes, and demonstrate that loss of ELK1 can be caused by cigarette smoke.
1. Introduction
Tissue fibrosis is a common pathogenic pathway that results in a
range of pathologies across several organs including the lung, liver,
skin, kidney and heart. Fibrosis of these tissues is responsible for more
than a third of deaths throughout the world (Wynn, 2008). There are
shared, and distinct, mechanisms that may lead to fibrosis in a number
of organs involving a range of cells which can provoke inflammation,
epithelial injury and fibroproliferation (Wynn, 2008; Weiskirchen et al.,
2019).
A key pathway promoting fibrosis involves integrin-mediated TGFβ
activation. Integrin-mediated TGFβ activation has been shown to be
important in fibrosis of the lung, liver, skin, cardiovascular system and
kidney (Henderson et al., 2013; Tatler and Jenkins, 2012; Popov et al.,
2008; Häkkinen et al., 2004; Hahm et al., 2007), with αvβ6 integrin-
mediated TGFβ activation being particularly important in the lung
(Tatler and Jenkins, 2012) while αvβ1 integrin-mediated TGFβ acti-
vation being considered more important for liver and kidney fibrosis
(Reed et al., 2015; Chang et al., 2017).
ELK1 is an X-linked transcription factor that regulates a range of
biological processes (Sharrocks, 2001). ELK1 is ubiquitously expressed
in a range of cell types and in a number of organs (Uhlén et al., 2015).
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We have previously demonstrated that ELK1 is a transcriptional re-
pressor that prevents excessive upregulation of the β6 integrin subunit
following injury (Tatler et al., 2016). Furthermore, we have shown that
loss of ELK1 leads to enhanced pulmonary fibrosis following bleomycin-
induced lung injury in mice and that patients with Idiopathic Pul-
monary Fibrosis (IPF) have reduced expression of ELK1 in their lungs
(Tatler et al., 2016).
Idiopathic fibrotic disease of many organs is associated with aging.
Therefore, we hypothesized that loss of ELK1 would lead to age-related
tissue fibrosis of internal organs due to loss of repressed integrin ex-
pression. To test this hypothesis Elk1-knockout (Elk1-−/0) mice were
allowed to age to one year after which their internal organs were as-
sessed for fibrosis. We demonstrated that the lungs and liver from
ELK1-/0 mice developed spontaneous age-related fibrosis whereas the
heart and kidneys were normal. To understand the potential mechanism
by which ELK1 may be lost in IPF, we exposed human lung epithelial
cells and murine lung slices to cigarette smoke extract (CSE) and con-
firmed that this reduced ELK1 protein levels. These studies illustrate the
importance of ELK1 in protection against tissue fibrosis and highlight a
mechanism through which this protective mechanism may be lost in
fibrosis.
2. Methods
2.1. Cell lines and reagents
Immortalised human bronchial epithelial cells (iHBECs; courtesy Dr
Shay, University of Texas) were used for cigarette smoke extract (CSE)
experiments. iHBECs were cultured in keratinocyte-serum free medium
(K-SFM; Gibco, UK) supplemented with 25 μg/ml bovine pituitary ex-
tract (Gibco, UK), 0.2 ng/ml epidermal growth factor (Gibco, UK), 25
μg/ml G418 sulphate (VWR Life Science, UK) and 250 ng/ml pur-
omycin (MilliporeSigma, UK). ELK1 #ab32106, β-tubulin #ab6046,
GAPDH #ab181602, αSMA #ab5694 and NIMP #ab2557 antibodies
for western blotting and/or immunohistochemistry (IHC) were from
Abcam, UK. CD3+ #MCA1477 and CD68 #OABB00472 antibodies for
IHC were obtained from Bio-rad, UK and Aviva Systems Biology, UK,
respectively. Reagents required for the synthesis of cDNA from RNA,
were supplied from Invitrogen, UK (SuperScript™ IV Reverse
Transcriptase), Qiagen, UK (Nuclease free water), Roche, UK (OligoDT)
or Promega, UK (RNasin inhibitor, dNTPs). Tobacco laboratory re-
search grade cigarettes (batch 1R6F) were from the University of
Kentucky, USA.
2.2. Invivo studies
All animal care and procedures were approved by the University of
Nottingham Ethical Review Committee and were performed under
Home Office Project and Personal License authority within the Animal
(Scientific Procedures) Act 1986. Animals were housed in the
Biomedical Services Unit, University of Nottingham. Male Elk1-
knockout (Elk1−/0) (Cesari et al., 2004) and wildtype (Elk1+/0) mice
were aged for 12 or 52 weeks with free access to food (Tekland Global
18 % protein rodent diet, UK) and water. Lungs, liver, kidneys and
heart were either removed and snap-frozen in liquid nitrogen and then
stored at −80 °C for mRNA and hydroxyproline assessment, or in-
sufflated with 10 % formalin (VWR chemicals, UK) at constant grav-
itational pressure (20 cm H2O) then paraffin wax embedded for his-
tology and immunohistochemistry.
2.3. Reverse transcription and quantitative polymerase chain reaction
(qPCR)
Murine lung, liver, kidney and heart tissue was ground into powder
in liquid nitrogen and RNA extracted using TRIzol using standard
methods. Alternatively, RNA from iHBECs were prepared using a
NucleoSpin RNA II kit (Macherey-Nagel, UK) according to manu-
facturer’s instructions. For detailed methods see supplementary
methods.
2.4. SDS-PAGE, western blot
Ground murine lung, liver, kidney and heart tissue as well as
Precision Cut Lung Slices (PCLS) and iHBECs were lysed in whole cell
lysis buffer (Cell Signaling, UK) supplemented with protease and
phosphatase inhibitors (Complete Mini protease inhibitor tablet and
Phos-stop inhibitor tablets; Roche, UK) and processed for im-
munoblotting using standard methods see supplementary methods
2.5. Histological assessment
Histological sections of murine lung, liver and heart tissue, were cut
to between 3–5 microns and dewaxed in xylene prior to rehydration in
decreasing concentrations of ethanol.
The sections were incubated in either Mayer’s haemotoxylin, and
eosin, Weigert’s haemotoxylin and Sirius red or Masson’s Trichrome
prior to dehydration and mounting. Tissue staining was imaged using
Nikon Eclipse 90i microscope and NIS Elements AR3.2 software
(Nikon). Heart tissue sections were scanned using a Hammamatsu
photonics K. K. C9600-02 and selected and captured using Hamamatsu
NDP.view2 software.
2.6. Immunohistochemistry
Tissue sections were also subjected to immunohistochemistry using
standard methods see supplementary methods.
2.7. Assessment of tissue fibrosis
The following scores were assigned to describe the severity of fi-
brosis in Sirius red stained liver sections; 0= normal, 0.5= very mild
fibrosis, 1= mild fibrosis, 2= fibrosis. The following scores were as-
signed to assess the grade of steatosis in H&E stained liver sections; 0 =
0–5 % steatosis, 1 = 5–33 %, 2 = 33–66 % and 3 =>66 % based on
the Brunt score (Brunt et al., 1999). Quantification of alveolar wall
thickness in lungs of Elk1−/0 and Elk1+/0 mice was performed as fol-
lows. 10 random fields of view were observed per tissue section. Each
field of view was overlaid with a graticule. The alveolar wall thickness
was measured each time it intercepted a horizontal line. The mean
value in μm was calculated for each mouse. All scoring was undertaken
blinded to the underlying genotype.
Biochemical assessment of tissue fibrosis was performed by mea-
suring hydroxyproline in murine lung tissue as previously described
(Uhlén et al., 2015).
2.8. Precision cut lung slices (PCLS)
6-week-old mice were euthanised and via a cannula to the trachea,
their lungs were slowly inflated using 1.3 ml 2 % low melting point
agarose in PBS followed by 0.2 ml air. Lungs were removed and placed
in ice cold DMEM supplemented with 4 % L-Glutamine, 4 % Penicillin/
Streptomycin and 2 % Amphotericin B (Gibco, UK). Lung lobes were
separated and sliced in chilled HBSS buffer at a thickness of 250 μm
using the VT1200S Vibratome (Leica) set to 1 mm amplitude, 1 mm/
second speed. The slices were then placed in warm supplemented
DMEM media and incubated overnight at 37 °C, 5 % CO2. The slices
were transferred to freezing media (FBS with 10 % DMSO) and stored
long-term in liquid nitrogen. PCLS were recovered by rapidly thawing
frozen vials at 37 °C and transferring them to fresh supplemented
DMEM for a period of 24 h at 37 °C, 5 % CO2 before use in subsequent
experiments. 3 PCLS were used per condition in CSE experiments.
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2.9. Preparation of CSE and experimental design
Cigarette Smoke Extract (CSE) was generated by smoking two to-
bacco laboratory research grade cigarettes (batch 1R6F) into 20 ml of
K-SFM media (iHBEC) or DMEM (PCLS) using a vacuum pump under a
constant pressure of 0.2 bar. Media was filter-sterilized and absorbance
was measured at 320 nm. Prepared CSE was aliquoted and stored at
−20 °C until required. From this 1, 2, 3, 4 and 5 % CSE were prepared
in K-SFM for iHBECs or DMEM (3 % CSE only) for PCLS. CSE was
prepared in this manner daily and applied for 7 days.
2.10. Statistics
All data are reported as mean± standard deviation (parametric) or
median (non-parametric) of n observations. Statistical significance for
parametric data was determined by either an unpaired t-test when
comparing two data fields or ANOVA for comparing multiple data
fields. Data that were not normally distributed were assessed by non-
parametric Mann-Whitney test to determine significance. CSE experi-
ments were repeated three times and expressed as mean data from the
three independent experiments. Statistical analysis of QPCR experi-
ments were performed using an unpaired Welch’s t-test. P values less
than 0.05 were considered significant. All statistical analysis was per-
formed using GraphPad Prism (v7.04, La Jolla, CA, USA).
3. Results
3.1. ELK1 is expressed in multiple internal organs
To determine the importance of baseline ELK1 expression in age-
related fibrosis, internal organs were harvested from mice at 1 year of
age followed by assessment of Elk1 mRNA and protein. Elk1 mRNA
(Fig. 1A) and ELK1 protein (Fig. 1B and C) were expressed at the
highest levels in the lung and heart tissue. In contrast, levels of Elk1
mRNA and protein were expressed at the lowest levels in the liver.
Levels of ELK1 in the kidneys were generally lower than the heart and
lungs but greater than observed in the liver (Fig. 1B and C).
3.2. Elk1−/0 mice develop age related pulmonary fibrosis
The lungs from 1-year old Elk1−/0 mice were assessed for evidence
of pulmonary fibrosis. Despite not being subjected to injury, hydro-
xyproline levels were mildly elevated in the lungs of Elk1−/0 animals
compared with controls (Fig. 2A). The elevated collagen levels in the
lungs of Elk1−/0 mice were reflected in the lung architecture with
features consistent with spontaneous lung fibrosis including small foci
of alveolar destruction with increased collagen deposition and areas of
lymphoid aggregates (Supplemental Fig. 1A). Analysis of these inter-
mittent small fibrotic lesions with Sirius red staining using polarised
light microscopy revealed that their composition was predominantly
type I collagen (yellow/orange strand) and type III collagens (green
strands) (Fig. 2B). This was confirmed using immunohistochemistry to
demonstrate that both type I and type III collagens are increased within
the lungs of aged Elk1-/0 animals compared with controls (Fig. 2C).
Furthermore, the alveolar walls of Elk1-/0 mice were thicker compared
with wild-type control lungs (Fig. 2D and E). Sirius Red staining re-
vealed that there was increased deposition of collagen III within the
alveolar interstitium (Fig. 2E). Analysis of collagen type 1, 3 and 6
mRNA expression (Fig. 2F) did not show any difference in Col1a1 and
Col6a1 mRNA expression between Elk1+/0 and Elk1−/0 animals. How-
ever, Col3a1 expression was significantly increased in Elk1−/0 mice
consistent with the increased interstitial collagen 3 seen histologically
(Fig. 2E). Interestingly, the phenomenon of thickened alveolar walls,
deposition of fibrosis and increased Col3a1 mRNA expression was not
observed in 12-week old Elk1−/0 mice (Supplemental Fig. 2A and 2B),
highlighting the importance of ageing in the development of this phe-
notype in Elk1−/0 mice. While inflammation is not thought to be a
major pathogenic pathway in IPF, inflammation is associated with some
forms of pulmonary fibrosis and so we investigated the presence of
activated T cells, neutrophils and macrophages in the lungs of the aged
animals. We found no difference in numbers of any of these cell types
between the lungs of aged Elk1-/0 and Elk1+/0 animals (Fig. 2G and
Supplemental Fig. 1B).
3.3. Elk1−/0 mice do not develop age related cardiac or renal fibrosis
As described earlier, ELK1 is expressed at high levels in the normal
heart, and to a lesser extent in the kidneys. Therefore, the heart and
kidneys were assessed for phenotypic abnormalities. There was no
evidence of fibrosis in the heart tissue of Elk1+/0 and Elk1−/0 animals
as determined either histologically or biochemically. Indeed, there was
a slight reduction of collagen in the hearts of Elk1−/0 animals compared
with controls (Fig. 3A), although morphological assessment of heart
sections using Sirius Red showed no abnormalities in tissue structure in
either wild-type or knock-out animals (Fig. 3B). In the kidneys of
Elk1+/0 and Elk1−/0 mice, there was no evidence of renal fibrosis
biochemically (Fig. 3C) or histologically (Fig. 3D).
3.4. Elk1−/0 mice develop hepatosteatosis
Although high levels of ELK1 were not observed in whole liver ly-
sates at either the mRNA or protein level in Elk1+/0 mice, there was
evidence of pathology on histology, in the livers of aged Elk1−/0 mice.
Liver sections from Elk1+/0 and Elk1−/0 aged mice, stained with Sirius
Red, demonstrated increased portal fibrosis and mild perisinusoidal
fibrosis in the Elk1−/0 animals compared with Elk1+/0 mice. In addi-
tion, Elk1−/0 mice also exhibited more micro- and macrosteatosis
shown by the blue and green arrows, respectively (Fig. 4A and B).
However, there was no increase in hydroxyproline levels in the livers of
Elk1−/0 mice (Supplementary Fig. 3).
To further explore the fibrotic phenotype in the liver,
Fig. 1. ELK1 expression in internal organs in wild-type animals.
(A) Elk1 mRNA expression in the lung, liver, kidney and heart tissues of 1-year
aged Elk1+/0 mice. n = 8, P values determined by one-way ANOVA.
(B) Representative western blot showing ELK1 protein expression in the lung,
liver, kidney and heart tissues of 1-year aged Elk1+/0 mice.
(C) Densitometry analysis showing the ratio of ELK1:β-tubulin. n = 8 mice.
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immunohistochemistry (IHC) was performed using a marker of hepatic
myofibroblasts. This demonstrated that alpha Smooth Muscle Actin
(αSMA) was not expressed in the livers of Elk1+/0, however αSMA
staining was increased in the livers from Elk1−/0 aged animals and
localised to the peri-portal and peri-sinusoidal regions (Fig. 4C).
In contrast with pulmonary fibrosis, liver fibrosis is more obviously
associated with inflammation, therefore sections were assessed for the
presence of inflammatory cells such as; activated T-cells (CD3), neu-
trophils (NIMP) as well as monocyte and macrophage populations
(CD68) (Fig. 4D). Quantification of the inflammatory cell populations
revealed a slight increase in the mean number of activated T-cells and
neutrophils in Elk1−/0 mice although not statistically different. How-
ever, there was a substantial, and statistically significant, increase in
the number of macrophages present in the livers from Elk1−/0 aged
animals compared with wild-type controls (Fig. 4D). Despite the ob-
vious fibrotic phenotype within the lungs and livers of aged Elk1-/0
animals, and the presence of fat within the livers, we observed no dif-
ference in animal body mass at 1 year between the two genotypes
Fig. 2. Elk1−/0 aged mice deposit collagen and
exhibit small fibrotic lesions in the lungs.
(A) Total lung collagen assessed by measuring
hydroxyproline levels in ground lung tissue
from 1-year aged Elk1+/0 and Elk1−/0 mice. P
value determined by unpaired t-test.
(B) Representative brightfield and polarised
light images of Sirius Red stained lung sections
from 1-year aged Elk1+/0 and Elk1−/0 mice.
Scale bar 50μm.
(C) Representative images of lung sections from
1-year aged Elk1+/0 and Elk1−/0 mice probed
for Collagen type I and Collagen type III. P
value determined by unpaired t-test. Scale bar
50μm.
(D) Quantification of alveolar wall thickness in
1-year aged Elk1+/0 and Elk1−/0 mice. P value
determined by Mann-Whitney test.
(E) Representative brightfield and polarised
light images of H&E and Sirius Red stained lung
sections from 1-year aged Elk1+/0 and Elk1−/0
mice. Scale bar 50μm.
(F) Col1a1, Col3a1 and Col6a1 mRNA expres-
sion in Elk1+/0 and Elk1−/0 in 1-year aged
mice were analysed using QPCR. Data were
expressed as mRNA expression fold-change re-
lative to Elk1+/0 mean of 1. P value determined
by t-test.
(G)Quantification of cell numbers of CD3 (ac-
tivated T-cells), NIMP (neutrophils) and CD68
(macrophages) positive cells in lung sections
from 1-year aged Elk1+/0 and Elk1−/0 mice.). P
value determined by unpaired t-test.
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Fig. 3. Elk1−/0 aged mice do not display any pathological abnormalities in the
kidney or heart.
(A)Total heart collagen assessed by measuring hydroxyproline levels in ground
heart tissue from 1-year aged Elk1+/0 and Elk1−/0 mice. P value determined by
unpaired t-test.
(B) Representative images of Sirius Red stained heart sections from 1-year aged
Elk1−/0 and Elk1+/0 mice.
(C)Total kidney collagen assessed by measuring hydroxyproline levels in
ground kidney tissue from 1-year aged Elk1+/0 and Elk1−/0 mice. P value de-
termined by unpaired t-test.
(D)Representative images of H&E stained kidney sections from 1-year aged
Elk1−/0 and Elk1+/0 mice.
Fig. 4. Elk1−/0 aged mice have mild hepatic fibrosis and steatosis in the ab-
sence of injury.
(A) Representative images of Sirius Red stained liver sections from 1-year aged
Elk1+/0 and Elk1−/0 mice showing mild fibrosis (red arrow), micro-steatosis
(blue arrows) and macro-steatosis (green arrows).
(B) H&E and Sirius Red stained liver sections from 1-year aged Elk1+/0 and
Elk1−/0 mice scored blind for fibrosis and steatosis. P values determined by
Mann-Whitney test.
(C) Representative images of liver sections from 1-year aged Elk1+/0 and
Elk1−/0 mice assessed for αSMA.
(D) Representative images of liver sections from 1-year aged Elk1+/0 and
Elk1−/0 mice probed for CD3 (activated T-cells), NIMP (neutrophils) and CD68
(macrophages). P value determined by unpaired t-test.
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(Supplemental Fig. 4).
3.5. Loss of Elk1 differentially affects integrin expression
To understand the phenotype of aged Elk1 mice we assessed mRNA
levels of key pro-fibrotic integrins in the lungs, liver and kidneys of
Elk1−/0 and Elk1+/0 animals. In the lungs of Elk1−/0 mice a significant
decrease in Itgb1 mRNA was seen compared with controls animals,
whereas Itgb5 levels were unchanged between Elk+/0 and Elk1-/0 ani-
mals. There was 1.5 fold increase in Itgb6 was observed in the lungs of
Elk1−/0 mice compared with Elk1+/0 mice although this did not reach
statistical significance (Fig. 5A).
Levels of Itgb6 were below the detection limits in the livers of both
Elk+/0 and Elk1−/0 animals (data not shown) and neither whole organ
expression of Itgb1 nor Itgb5 mRNA expression were different between
Elk1-/0 mice and control animals (Fig. 5B).
The kidneys, however, showed a marked reduction in Itgb6 mRNA
levels in Elk1−/0mice and conversely approximately a two fold increase
in Itgb5 whicxh was statistically significant and Itgb1 levels which did
not reach statistical significance (Fig. 5C).
3.6. Loss of ELK1 can be acquired following inhalation injury
We have previously shown that Elk1−/0mice exhibit an exaggerated
fibrotic response to bleomycin induced fibrosis compared with Elk1+/0
controls and that IPF patients have lower levels of Elk1 protein in their
lungs (Uhlén et al., 2015). We investigated whether ageing caused a
decrease in Elk1 expression in the 1-year old Elk1+/0 mice compared
with 12-week-old Elk1+/0 mice and found no difference in expression
(Supplementary Fig. 5). Genetic studies have not identified an asso-
ciation with loss of function Elk1mutants and pulmonary fibrosis, and it
remains unclear whether ELK1 levels can be altered following injury.
Therefore, the effect of prolonged exposure to a known fibrogenic risk
factor in human disease, cigarette smoke extract (CSE), on epithelial
ELK1 expression was assessed.
Levels of Elk1mRNA in iHBECs changed in a time and concentration
Fig. 5. Loss of ELK1 has organ-specific effects on integrin transcription.
(A)Itgb1, Itgb5 and Itgb6 mRNA expression in the lungs of 1-year aged Elk1+/0 and Elk1−/0 mice. Data were expressed as mRNA expression fold-change relative to
Elk1+/0. P values were determined by Welch’s t-test.
(B) Itgb1 and Itgb5 mRNA expression in the livers of 1-year aged Elk1+/0 and Elk1−/0 mice were analysed using QPCR. Data were expressed as mRNA expression fold-
change relative to Elk1+/0. P values were determined by Welch’s t-test.
(C)Itgb1, Itgb5 and Itgb6 mRNA expression in the kidneys of 1-year aged Elk1+/0 and Elk1−/0 mice were analysed using QPCR. Data were expressed as mRNA
expression fold-change relative to Elk1+/0. P values were determined by Welch’s t-test.
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dependent manner following culture in CSE, with early time-points
demonstrating an increase in Elk1 particularly at higher concentrations,
whereas, by day 5 exposure to CSE Elk1mRNA levels were reducing and
by day 7 Elk1 mRNA levels were lower than controls (Fig. 6A).
Western blot of lysates obtained from iHBECs exposed to 3 % CSE
led to reduced ELK1 after 7 days of exposure, which was confirmed by
densitometric analysis (Fig. 6B).
To confirm the results of in vitro cell cultures, precision cut lung
slices (PCLS) obtained from uninjured lungs from wild-type mice were
exposed to either 0 or 3 % CSE for 7 days. Levels of ELK1 protein re-
duced by 50 % in PCLS exposed to 3 % CSE (Fig. 6C).
4. Discussion
IPF specifically, and fibrotic diseases more generally, affect pri-
marily the elderly and have been associated with age-related processes
such as telomere shortening (Cronkhite et al., 2008; Armanios et al.,
2007; Alder et al., 2008). We have previously identified a repressive
role for the transcription factor ELK1 in the pathogenesis of IPF and
have demonstrated that mice without ELK1 have an exaggerated
fibrotic response to lung injury through loss of repression of αvβ6 in-
tegrin mediated TGFβ-activation (Uhlén et al., 2015). We therefore
hypothesized that if the ELK1 transcriptional repression was important
for the regulation of homeostatic functions of the αvβ6 integrin then
mice with global deficiency of Elk1 would develop age-related fibrotic
changes.
We assessed the phenotype of Elk1−/0 mice aged for 12 months
without injury and found that these mice developed features consistent
with pulmonary fibrosis despite the absence of injury. This is unusual in
many genetic models of lung fibrosis which often require a second “hit”
to promote fibrosis (Moore et al., 2013), although this may be due to
the small number of studies that have looked at the effect of ageing in
genetically modified mice. Some age-related studies include Relaxin-/-
mice have been shown to develop features consistent with small airway
fibrosis and renal fibrosis (Samuel et al., 2003, 2004). Furthermore,
specific deletion of the telomere shelterin protein TRF1 also leads to age
dependent lung fibrosis (Naikawadi et al., 2016), as well as, mutations
in genes with causal associations with IPF (Cheng et al., 2005;
Blackwell, 2018). It is therefore apparent that genetic changes can
promote spontaneous fibrosis across a range of organs.
Fig. 6. Prolonged exposure to CSE in the lungs results in the loss of ELK1.
(A) Human ELK1 and GAPDH (house-keeping gene) mRNA expression levels were analysed by qPCR in iHBECs treated with 0, 1, 2 or 3 % CSE for 3, 4, 5 or 7 days (T).
(B) Representative western blot of iHBECs treated with 0, 1, 2 or 3 % CSE for 3, 4, 5 or 7 days (T). Densitometry of western blot data normalised to 0 % CSE control
for equivalent time point. P values determined by one-way ANOVA, 0 % vs 3 % CSE at T7 (n = 3).
(C) Representative western blot showing protein expression of ELK1 in PCLS treated with 3 % CSE for 7 days. N = 3.
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It is interesting to note that the fibrotic phenotype in ELK1 deficient
animals did not map onto the organs with the highest levels of ELK1 in
wild-type animals. Although these data did not show a significant in-
crease in Itgb6mRNA in whole lung lysates from aged Elk1−/0 mice, the
direction and magnitude of change were similar our previous studies
which identified that loss of ELK1 promotes lung fibrosis through en-
hanced expression of the epithelial specific β6 integrin subunit Tatler
et al., 2016. This may explain why no phenotype relating to cardiac
fibrosis was observed as epithelial injury and αvβ6 integrins are not
primarily involved in fibrogenesis of the heart, where other αv integrins
are involved (Murray et al., 2017).
Loss of ELK-1 also lead to mild liver fibrosis as assessed by Sirius red
staining, although there was no increase in liver hydroxyproline levels.
This may reflect the mild nature of the fibrosis, possibly below the level
of sensitivity for this assay, and the fact that fatty liver was the major
phenotype observed. Within the liver it is possible that ELK1 may
regulate αvβ6 expression, although loss of the β6 integrin subunit did
not protect against CCl4 induced hepatic fibrosis (Henderson et al.,
2013) and levels of Itgb6 mRNA were undetectable in whole lung ly-
sates. It is interesting to note that despite the presence of considerably
more fat in the livers of Elk1−/0 mice compared with wild-types, there
was no difference in their body weight growth curves over the 1-year
period (Supplemental Fig. 4) suggesting that ELK1 has a direct hepta-
toprotective effect. We cannot exclude that cell specific loss of ELK1
mediated repression of αvβ6 integrins may be involved in the observed
phenotype, and indeed loss or inhibition of the αvβ6 integrin has been
shown to protect against biliary fibrosis and biliary cells make up only a
small proportion of the total liver cell population and it is therefore
likely that any increase in cholangiocyte αvβ6 expression was not ob-
served in the whole liver lysates used in this study (Popov et al., 2008;
Wang et al., 2007). Previous studies have suggested that the αvβ1 in-
tegrin is a profibrotic integrin in both the lung and liver (Henderson
et al., 2013), however we consider it unlikely that ELK1 is mediating
protective affects via Itgb1 as loss of ELK lead to a reduced Itgb1 in the
lung and was unchanged in the liver, although again we can’t exclude
cell specific effects.
Intriguingly, kidneys from Elk1−/0 mice did not show any fibrotic
phenotype despite a well-established role of the αvβ6 integrin in renal
fibrosis. Ischaemia reperfusion injury in rat kidneys promotes αvβ6
expression and TGFβ activation (Geng et al., 2012). In a UUO model of
renal fibrosis, mice are partially protected by loss of β6 integrin and
similarly Alport mice are protected from fibrosis by administration of a
β6 blocking antibody (Hahm et al., 2007; Ma et al., 2003). However, it
is notable that loss of ELK1 in the kidneys had a profound effect on
reducing Itgb6 expression in the kidneys suggesting that in this organ
ELK1 acts a transcriptional activator of Itgb6, rather than as a repressor.
It is known that post-transcriptional modifications of ELK1 can affect its
function (Chung et al., 1998; Yang et al., 2003; Yang and Sharrocks,
2004). We hypothesise that exposure to renal specific substrates may
promote a distinct post-transcriptional profile, such as an excess of
sumoylated ELK1, in the renal tract compared with the lung.
The role of the αvβ1 integrin in renal fibrosis is highly cell specific
with deletion of β1 in collecting duct principle cells promoting fibrosis
(Mamuya et al., 2017) but, loss of fibroblast αvβ1 integrins ameliorates
it (Henderson et al., 2013; Chang et al., 2017). The data presented here
show a mild and insignificant increase in Itgb1 mRNA expression which
may explain the lack of fibrosis in this aged model. However, levels of
Itgb1 mRNA may not truly reflect cell surface expression of αvβ1 in-
tegrins as β1 integrin subunits are produced in excess within a cell and
it is expression levels of the α subunit that governs expression for β1
containing heterodimers. Unlike the lung and the liver, Itgb5 is in-
creased in the kidneys of Elk1−/0mice at the message level compared to
controls and increased myofibroblast expansion has been associated
with increased αvβ5 levels in the kidney (McCurley et al., 2017). It is
clear from our studies that there are cell and organ specific effects of
ELK1 on the regulation of the different integrin subunits which are
likely to determine the fibrotic phenotype associated with aging.
This study provides detailed phenotyping of uninjured age-related
fibrosis in Elk1−/0 mice, including the identification of ELK1 as an age-
dependent mediator of lung and liver fibrosis in male C57BL/6 mice.
Both lung and liver fibrosis occur in older people and this is especially
the case for patients with idiopathic pulmonary fibrosis where there is
no clearly identifiable aetiological agent. It is not clear how ELK1 may
be lost over time to promote disease and our data suggest that ageing
itself is not sufficient to cause a loss of Elk1 expression. Genetic studies
have not identified an association with ELK-1, or indeed polymorphisms
in the X chromosome and pulmonary fibrosis, similarly no changes have
been found associating the ELK-1 epigenome and IPF. These data sug-
gest that cigarette smoke can, in principle, reduce ELK1 expression.
Therefore, we hypothesise that cigarette smoking may reduce ELK1
which may over time may promote fibrosis.
As the Elk1 gene is located on the X chromosome, there are parti-
cular benefits to using only male mice in these studies including elim-
inating the effects of female hormones on the fibrotic response (Han
et al., 2008). Whilst ageing the mice beyond one year may have further
exaggerated the age-related fibrotic effects and given more dramatic
phenotypes it is reassuring that a phenotype was observed after only 12
months. A further strength is the application of a known fibrosis risk
factor on both a cell line and physiologically viable PCLS both de-
monstrating a link between smoking and the loss of ELK1. These studies
do however have some limitations. Most notably the use of im-
mortalised epithelial cells may not recapitulate the response of primary
alveolar epithelial cells. Furthermore, due to the breeding strategy re-
quired for the gene deletion of ELK1 on the X chromosome these studies
were limited to males and therefore the biological effect of sex on the
development of fibrosis cannot be assessed.
In conclusion, our data support a role for the loss of ELK1 in pro-
moting age-related fibrosis in both the lung and liver. These data also
highlight the organ-specific effects of ELK1, including a differential
effect on Itgb6 in the lung and kidney, where ELK1 appears to act as a
transcriptional activator of Itgb6 gene expression. Finally, exposure to
known fibrogenic risk factors can reduce expression of ELK1 in the lung
epithelium, which may in part explain how cigarette smoke increases
the risk of IPF. These findings highlight the importance of normal
functioning ELK1 in protecting two major organs from age related fi-
brosis.
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